Drawing on the results showing that the higher MSI proportion and E-Cadherin downregulation were particularly enriched in group IV*, we explored whether there was an association between the CMS and colon cancer risk subgroups stratified by IDO1 and CD8A expression using the TCGA data. The gene discussed is IDO1; the disease is malignant colon neoplasm.